Moreover, they found an increase in PTEN loss (30% vs. 11%, q < 0.001) and Adenomatous Polyposis Coli (APC) mutations (11% vs. 5%, q = 0.001), the latter being another tumor suppressor gene implicated in prostate carcinogenesis [11,87]. This evidence concerns the gene APC and medical procedure.